There were 1,211 press releases posted in the last 24 hours and 191,412 in the last 365 days.
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life- …
SAN FRANCISCO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its third quarter 2020 financial results on Thursday, November 5 after the market close. FibroGen will also conduct a conference call on that day at 5:00 p.m. ET ( …
WATERTOWN, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, will report results for its third quarter 2020 on …
-- Treated first patients in Phase 2 dose-ranging trial for EDP1815 in psoriasis -- -- Six clinical readouts in psoriasis, atopic dermatitis, COVID-19, and breast cancer expected over next 3-9 months -- --Advancing newly discovered microbial extracellular …
– XBAW Filters Aimed at Last Mile Connectivity Solution Using Recently Auctioned CBRS Band – – Customer’s Technology Targeting Mobile, Cable, ISP and Other Operators with High-Speed Alternative to Fiber – Charlotte, N.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- …
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, …
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new scientific findings that add to the growing body of knowledge on VASCEPA® (icosapent ethyl) in patients at risk for major …
Initiated GEN-011 Phase1/2a clinical trial Presented positive follow-up GEN-009 Part B data at ESMO Virtual Congress 2020 demonstrating potential added benefit to PD-1 inhibitor therapy Closed financing with net proceeds of $74.5 million Upcoming …
IRVINE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global provider of Software as a Service (SaaS), engineering services and hardware for Edge Computing, the Internet of Things (IoT) and Remote Environment Management (REM), …
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the appointment of Charles Williams as chief financial officer. An experienced …
SparingVision Strengthens Management Team ·Dr. Florence Lorget to lead development sciences as Chief Development Sciences Officer ·Dr. Rajiv Gangurde to lead manufacturing operations as Chief Technology Officer ·Both positions are US- …
Inivata Announces Collaboration with Maverick Therapeutics for use of RaDaR™ Assay RaDaR ctDNA liquid biopsy test to be used to monitor patient response in Phase 1/2 study of MVC-101 in multiple tumor types Research Triangle Park, NC, USA and …
Immatics’ first TCR Bispecific program IMA401 delivers preclinical proof-of-concept demonstrating complete remissions of transplanted human tumors in mice and favorable CMC characteristics The IMA401 target, an HLA-A*02-bound peptide derived both from …
Net sales of $747 million; 3% increase Y/Y excluding currency Net income of $6 million or $0.21 per diluted share Adjusted net income of $38 million or $1.36 per diluted share, excluding restructuring charges Adjusted EBITDA of $87 million, 11.6% of sales …
BERWYN, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced it resumed …
TORONTO and CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the …
MACAU, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Trip.com Group, a leading online travel services provider, today officially extended its charter flight service business in Macau. From October 29 to October 31, Trip.com Group is showcasing its new air charter …
SAN DIEGO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced that it received a notice of allowance for application number 16/292,388, which was filed on March 5, 2019, issued by the United …
Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease IL-18 driven monogenic Hemophagocytic Lymphohistiocytosis (HLH) WuXi Biologics to undertake commercial scale manufacturing to support U.S. market launch LAUSANNE, …
SAN FRANCISCO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- RiskIQ, a global leader in attack surface management, today announced that RiskIQ PassiveTotal now integrates directly with Microsoft Defender for Endpoint and Azure Sentinel. The integration brings Defender …
Don’t miss any breaking news!
Get the EIN Presswire App
Power your mobile with the latest breaking news by country, US state or industry.
